feed,title,long_url,short_url
SeekingAlpha,Axsome stock rises 9% as company eyes potential approval/launch of drugs in FY22,https://seekingalpha.com/news/3807812,
SeekingAlpha,Avenue Therapeutics trebles in value on rising volume,https://seekingalpha.com/news/3807817,
SeekingAlpha,Luminar Technologies stock pop on Q4 results,https://seekingalpha.com/news/3807816,
SeekingAlpha,RedHill Biopharma COVID treatment reduces severe symptoms in mid-stage trial,https://seekingalpha.com/news/3807813,
SeekingAlpha,First active pure-play U.S. residential real estate ETF hits the market,https://seekingalpha.com/news/3807800,
SeekingAlpha,Chevron surges after hiking stock buyback plans to as much as $10B annually,https://seekingalpha.com/news/3807814,
